171 related articles for article (PubMed ID: 34620073)
1. Repurposing Drugs to Combat Drug Resistance in Leprosy: A Review of Opportunities.
Sharma M; Singh P
Comb Chem High Throughput Screen; 2022; 25(10):1578-1586. PubMed ID: 34620073
[TBL] [Abstract][Full Text] [Related]
2. A Perspective into "TEL"-Tenofovir, Emtricitabine and Lamivudine Antileprotic Activities by Drug Repurposing and Exploring the Possibility of Combination Chemotherapy with Drug Rescued Molecules for a Leprosy Free Mankind.
Thangaraju P; Yella SST; Ramamurthy VA; Navabshan I; Mohamed TALH
Recent Adv Antiinfect Drug Discov; 2023; 18(3):170-177. PubMed ID: 36803758
[TBL] [Abstract][Full Text] [Related]
3. An Overview of Treatment Guidelines and Methods of Synthesis of Drugs Used in Leprosy Chemotherapy.
Pinheiro LCS; Borges JC; Campos VR; Dantas LC
Mini Rev Med Chem; 2023; 23(4):497-512. PubMed ID: 35430972
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of anti-bacterial activity of Rifapentine, Clarithromycin, Minocycline, Moxifloxacin, Ofloxacin and their combinations in Murine Model of Rifampicin Resistant Leprosy.
Joseph P; Ponnaiya J; Das M; Chaitanya VS; Arumugam S; Ebenezer M
Indian J Lepr; 2016; 88(3):147-58. PubMed ID: 30207440
[TBL] [Abstract][Full Text] [Related]
5. Drug resistant-Mycobacterium leprae--results of mouse footpad studies from a laboratory in south India.
Ebenezer GJ; Norman G; Joseph GA; Daniel S; Job CK
Indian J Lepr; 2002; 74(4):301-12. PubMed ID: 12624978
[TBL] [Abstract][Full Text] [Related]
6. Interaction of constituents of MDT regimen for leprosy with Mycobacterium leprae HSP18: impact on its structure and function.
Chakraborty A; Ghosh R; Biswas A
FEBS J; 2022 Feb; 289(3):832-853. PubMed ID: 34555271
[TBL] [Abstract][Full Text] [Related]
7. Molecular detection of multidrug-resistant Mycobacterium leprae from Indian leprosy patients.
Lavania M; Singh I; Turankar RP; Ahuja M; Pathak V; Sengupta U; Das L; Kumar A; Darlong J; Nathan R; Maseey A
J Glob Antimicrob Resist; 2018 Mar; 12():214-219. PubMed ID: 29097343
[TBL] [Abstract][Full Text] [Related]
8. Drug resistance in leprosy: An update following 70years of chemotherapy.
Aubry A; Sammarco Rosa P; Chauffour A; Fletcher ML; Cambau E; Avanzi C
Infect Dis Now; 2022 Aug; 52(5):243-251. PubMed ID: 35483633
[TBL] [Abstract][Full Text] [Related]
9. Study of rifampicin resistance and comparison of dapsone resistance of M. leprae in pre- and post-MDT era.
Gupta UD; Katoch K; Katoch VM
Indian J Lepr; 2009; 81(3):131-4. PubMed ID: 20509341
[TBL] [Abstract][Full Text] [Related]
10. Evidence for
Mahajan NP; Lavania M; Singh I; Nashi S; Preethish-Kumar V; Vengalil S; Polavarapu K; Pradeep-Chandra-Reddy C; Keerthipriya M; Mahadevan A; Yasha TC; Nandeesh BN; Gnanakumar K; Parry GJ; Sengupta U; Nalini A
Am J Trop Med Hyg; 2020 Mar; 102(3):547-552. PubMed ID: 31933458
[TBL] [Abstract][Full Text] [Related]
11. The frequency of drug resistance mutations in Mycobacterium leprae isolates in untreated and relapsed leprosy patients from Myanmar, Indonesia and the Philippines.
Matsuoka M; Budiawan T; Aye KS; Kyaw K; Tan EV; Cruz ED; Gelber R; Saunderson P; Balagon V; Pannikar V
Lepr Rev; 2007 Dec; 78(4):343-52. PubMed ID: 18309708
[TBL] [Abstract][Full Text] [Related]
12. Emergence and Transmission of Drug-/Multidrug-resistant Mycobacterium leprae in a Former Leprosy Colony in the Brazilian Amazon.
Rosa PS; D'Espindula HRS; Melo ACL; Fontes ANB; Finardi AJ; Belone AFF; Sartori BGC; Pires CAA; Soares CT; Marques FB; Branco FJD; Baptista IMFD; Trino LM; Fachin LRV; Xavier MB; Floriano MC; Ura S; Diório SM; Delanina WFB; Moraes MO; Virmond MCL; Suffys PN; Mira MT
Clin Infect Dis; 2020 May; 70(10):2054-2061. PubMed ID: 31260522
[TBL] [Abstract][Full Text] [Related]
13. Drug resistance patterns in Mycobacterium leprae isolates from relapsed leprosy patients attending The Leprosy Mission (TLM) Hospitals in India.
Lavania M; Jadhav RS; Chaitanya VS; Turankar R; Selvasekhar A; Das L; Darlong F; Hambroom UK; Kumar S; Sengupta U
Lepr Rev; 2014 Sep; 85(3):177-85. PubMed ID: 25509718
[TBL] [Abstract][Full Text] [Related]
14. Case Report: Multidrug-Resistant
Kamat D; Narang T; Ahuja M; Lavania M; Dogra S
Am J Trop Med Hyg; 2020 Apr; 102(4):724-727. PubMed ID: 32043454
[TBL] [Abstract][Full Text] [Related]
15. Drug-resistant M leprae.
Saunderson PR
Clin Dermatol; 2016; 34(1):79-81. PubMed ID: 26773627
[TBL] [Abstract][Full Text] [Related]
16. Recent Advancement in the Diagnosis and Treatment of Leprosy.
Aamir M; Sadaf A; Khan S; Perveen S; Khan A
Curr Top Med Chem; 2018; 18(18):1550-1558. PubMed ID: 30360715
[TBL] [Abstract][Full Text] [Related]
17. Dapsone drug resistance in the MDT era.
Roche PW; Neupane KD; Failbus SS; Butlin CR
Int J Lepr Other Mycobact Dis; 2000 Sep; 68(3):323-5. PubMed ID: 11221097
[No Abstract] [Full Text] [Related]
18. Drug resistance in leprosy: lessons from past and future perspective.
Gupta UD; Katoch VM
Indian J Lepr; 1999; 71(4):451-63. PubMed ID: 10804973
[TBL] [Abstract][Full Text] [Related]
19. [Leprosy – an old infectious disease with unsolved matters].
Stock I
Med Monatsschr Pharm; 2016 Dec; 39(12):522-6. PubMed ID: 29979513
[TBL] [Abstract][Full Text] [Related]
20. Treatment of leprosy.
Kar HK; Gupta R
Clin Dermatol; 2015; 33(1):55-65. PubMed ID: 25432811
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
